The global cevimeline drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Cevimeline drug is used in certain immune diseases which causes eyes and mouth dryness. Sjogren’s syndrome is a condition in which eyes and mouth become dry and lose moistness. This syndrome often accompanies other body ailments such as rheumatoid arthritis and lupus. This syndrome is accompanied by dysfunctioning of mucous membrane and moisture secreting glands of body parts. This condition results in a decrease in the amount of saliva and tears which are produced in the body. Sjogren’s syndrome can develop at any, however, is mostly seen in people who are above 40 years. This syndrome is common in females and focus is made on decreasing symptoms at the time of treatment. Eyes might seem to burn or feel as if there is sand in them. In the case of dry mouth, patients feel as if their mouth is filled with cotton. There is difficulty in speaking and swallowing. Health experts are of the view that this ailment is caused by genetic imbalance.
Some major players in the market include Daiichi Sankyo, Inc., Cosette Pharmaceuticals, Inc., and Lupin Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in Jan 2022, Cosette Pharmaceuticals, Inc. acquire manufacturing rights of eight branded products from Daiichi Sankyo in the US. One major drug among them is EVOXAC (cevimeline) which is used to treat Sjogren’s syndrome. The company mentioned that this has been done to expand their oncology portfolio in the US and be a global top 10 in this segment. This step will take 30 months during which both companies will manage their resources and transfer responsibility between them.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Cevimeline Drug Market market at:
https://orionmarketreports.com/request-sample/?id=94035&submit=Request+Sample%0D%0A
Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Distribution Channel
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Top Major Key Players:
Daiichi Sankyo, Inc., Cosette Pharmaceuticals, Inc., and Lupin Ltd., among others.
A full report of Cevimeline Drug Market market is available at:
https://orionmarketreports.com/cevimeline-drug-market/94035/
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Cevimeline Drug Market Report By Segment
By Distribution Channel
Hospital Pharmacies
Drug Stores
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
